Maribavir Impurity 9
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

176161-55-0Maribavir Impurity 9

● In Stock

Catalogue No.:VE0028061
CAS No.:176161-55-0
Mol. Formula:C10H11Cl2N3
Mol. Weight:244.12 g/mol

Additional information on CAS 176161-55-0

Parent drug

Maribavir

IUPAC Name

5,6-Dichloro-N-isopropyl-1H-benzo[d]imidazol-2-amine

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

CC(NC1=NC2=CC(Cl)=C(Cl)C=C2N1)C

InChI

InChI=1S/C10H11Cl2N3/c1-5(2)13-10-14-8-3-6(11)7(12)4-9(8)15-10/h3-5H,1-2H3,(H2,13,14,15)

Description

Maribavir Impurity 9 (CAS 176161-55-0) is a characterized process-related impurity encountered during maribavir API synthesis and stability studies. Analytical characterization by HPLC, LC-MS and NMR establishes its retention time, exact mass and diagnostic fragments, enabling reliable identification and quantification at trace levels. Detailed knowledge of its formation pathway, physicochemical properties including solubility and thermal behavior, and potential contribution to assay variability supports development of targeted control strategies and specification limits. Routine monitoring using validated methods coupled with optimized purification minimizes its presence to meet regulatory thresholds and preserve API purity and batch-to-batch consistency.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url